Evidence mapPaperPMID 42133239Full record

ArticleAdvanced biotechnology2026

Design and validation of a ribosome display library for synthetic nanobody selection.

Weijie Gu, Yaning Li, Jingjing Hong, Zhihao Yue, Yudi Zhang, Shuting Fan, Zhaowen Shen, Tingting Li, Dianfan Li

Abstract read
In one paragraph

Article in Advanced biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Weijie Gu *Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, University of CAS, Chinese Academy of Sciences, 320 Yueyang Road, Shanghai, 200031, China.
Yaning Li *Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, University of CAS, Chinese Academy of Sciences, 320 Yueyang Road, Shanghai, 200031, China.
Jingjing Hong *Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, University of CAS, Chinese Academy of Sciences, 320 Yueyang Road, Shanghai, 200031, China.
Zhihao YueSchool of Agriculture and Biotechnology, Sun Yat-Sen University, Shenzhen, China.
Yudi ZhangCenter for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, University of CAS, Chinese Academy of Sciences, 320 Yueyang Road, Shanghai, 200031, China.
Shuting FanSchool of Agriculture and Biotechnology, Sun Yat-Sen University, Shenzhen, China.
Zhaowen ShenSchool of Agriculture and Biotechnology, Sun Yat-Sen University, Shenzhen, China.
Tingting LiSchool of Agriculture and Biotechnology, Sun Yat-Sen University, Shenzhen, China. litt226@mail.sysu.edu.cn.ORCID http://orcid.org/0000-0003-3146-2761
Dianfan LiSchool of Agriculture and Biotechnology, Sun Yat-Sen University, Shenzhen, China. lidf9@mail.sysu.edu.cn.

Funding

National Natural Science Foundation of China 32471246National Natural Science Foundation of China 32571459National Natural Science Foundation of China W2412096
6 · The paper itself

Abstract

Single-domain antibodies (nanobodies) are compact, highly engineerable binding scaffolds widely used in structural biology, biotechnology, and therapeutics. When combined with the Legobody toolkit, they enable high-resolution cryo-electron microscopy (cryo-EM) analysis of small membrane proteins. Ribosome display is a powerful method for generating synthetic nanobodies (sybodies) with exceptionally high library diversity. However, existing sybody libraries are incompatible with the Legobody system, necessitating additional subcloning steps that reduce throughput and limit efficiency. Here, we report the rational design of a new ribosome-display-compatible nanobody library, termed S1.0, engineered for intrinsic compatibility with the Legobody platform through modifications in the C-terminal region. Compared to a benchmark sybody library, S1.0 features increased randomization in the complementarity-determining regions CDR1 and CDR3, while exhibiting reduced variability in CDR2. Selection against calmodulin demonstrated comparable efficiency to the benchmark library. Moreover, selection against thermostable green fluorescent protein (TGP) yielded multiple high-affinity sybodies, with nanomolar dissociation constants validated by size-exclusion chromatography and biolayer interferometry. Importantly, the selected sybodies are directly compatible with the Legobody system without requiring further engineering or subcloning. The S1.0 library represents a valuable resource for nanobody discovery and, in particular, provides an efficient route for generating Legobody-compatible binders suitable for structural studies of challenging small proteins by cryo-EM.

Indexed as

Green fluorescence proteinNanobody selectionRibosome displaySingle-chain antibodySynthetic nanobody

Identifiers

PMID42133239
PMCPMC13176400

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.